Tech Times on MSN
Moderna's mRNA Ebola vaccine enters human trials: Platform speed meets cold-chain wall in Ituri
Moderna mRNA Ebola vaccine mRNA-1469 entered Phase 1 trials in Canada on August 4, 2026 — making Canada the second country, after the UK, to test a Bundibugyo-specific shot. The mRNA platform's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results